Medicine and Science from The BMJ

Guidelines encourage the use of self monitoring of blood pressure in pregnancy, and research suggests that women prefer it. But Richard McManus, GP and professor of primary care at the University of Oxford explains that our enthusiasm may run ahead of the evidence and call for more research before it is routinely adopted. Read the full analysis: http://www.bmj.com/content/349/bmj.g6616

The incidence and prevalence of Crohn’s disease is increasing worldwide, and a clinical review on thebmj.com provides a practical approach to the diagnosis, management, and long term care of patients with Crohn’s disease. To help us understand what it’s like to have this condition, we're joined by Sarah, who was diagnosed with Crohn’s 13 years ago when she was 18. Read the full clinical review: http://www.bmj.com/content/349/bmj.g6670

A clinical review on thebmj.com looks at Meniere’s disease. One of the review's authors, Jonny Harcourt, a consultant otologist at Charing Cross Hospital in London, takes us through the pathogenic process and clinical presentation of the disease, its clinical course and prognosis, and what clinical features help to discriminate the condition from other diagnoses. He also discusses the evidence for treatment. In a second interview Corine from The Netherlands discusses her experience of having the disease, and offers her tips to others with the condition. https://soundcloud.com/bmjpodcasts/menieres-disease-patient Read the full review: http://www.bmj.com/content/349/bmj.g6544

A clinical review on thebmj.com looks at Meniere's disease. Corine from The Netherlands discusses her experience of having the disease and explains how the symptoms of vertigo and tinnitus have affected her everyday life. She also offers her top tips on coping with the disease to others with the condition. In a second podcast, Jonny Harcourt, a consultant otologist at Charing Cross Hospital in London and one of the authors of the review, takes us through the clinical course and prognosis of the disease. https://soundcloud.com/bmjpodcasts/menieres-disease Read the full review: http://www.bmj.com/content/349/bmj.g6544

Large trials show that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. So why does the European Medicines Agency still allow its use? Helen Macdonald, analysis editor for The BMJ, discusses the issue with Christiane Hartog, a lecturer in intensive care medicine at Jena University Hospital in Germany, and one of the authors of an analysis paper on thebmj.com Read the full analysis paper: www.bmj.com/content/349/bmj.g5981

Surgeon, writer, and researcher, Atul Gawande is best known for the development of surgical checklists, but the death of his father has inspired him to write his latest book exploring medical and societal attitudes to death. We joined him for breakfast during his whistle stop tour of the UK recording this year's BBC Reith Lectures, to discuss Being Mortal.

In a GMC survey last year, the UK’s surgical trainees came bottom of the list when it came to satisfaction about their training. Today, Craig McIlhenny, Director of the faculty of surgical training at the Royal college of surgeons of Edinburgh has released a report with a series of recommendations to improve standards of training, and he hopes, help it come inline with the European Working Time Directive Read his full report http://goo.gl/kH55lW

Fatoumata Nafo-Traoré is the executive director of the Roll Back Malaria Partnership. In this podcast, she updates us on recent successes in the global effort to control the disease. A second podcast examines the effect of the current ebola outbreak on the prevention and treatment of malaria, and other diseases, in affected regions.

Fatoumata Nafo-Traoré is the executive director of the Roll Back Malaria Partnership, and has just returned from Sierra Leone and Guinea. In this podcast, she describes the effect of the west African ebola outbreak on the prevention and treatment of malaria, and other diseases, in affected regions. In an earlier podcast, Dr Nafo examined recent successes in the global effort to control malaria.

A thrice failed antidepressant is at the centre of a new marketing campaign to win approval for what could become the world’s first blockbuster sex pill for women. Frustrated by the drug’s repeated rejection, proponents have orchestrated a fierce attack, accusing the regulator of unfairness, and enlisting support from several well connected women’s organisations in the US. Critics counter that the campaign is exceedingly misleading, that it targets a desire disorder that does not exist, and that approval could see widespread overprescribing of a drug with marginal benefits and real safety concerns. Ray Moynihan has investigated for The BMJ, and talks to Rebecca Coombes about the way this publicity campaign has been orchestrated. Read the full feature: http://www.bmj.com/content/349/bmj.g6246